Information about Lithi - Pharma
My details
*
*
*

Lithi - Pharma (SA)

Company information

Status
Active

Enterprise number

BE0449.135.041

VAT liability
Yes
Established
06-01-1993
Last balance sheet year
2025
Company size
Small 0 FTE
Principal activity
Activities of fitness centres
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Lithi - Pharma

2025 2024 2023 2022
Profit/Loss -223,557 -1118 % -18,359 -115 % 119,769 324 % 28,249
Equity 553,324 -29 % 776,881 -2 % 795,240 18 % 675,471
Gross margin 149,752 264 % 41,181 -80 % 204,719 65 % 124,145

Publications from Lithi - Pharma

Date Publication
02-12-2022 Goal - General meeting (NL)
06-01-2022 Resignations - Appointments (NL)
11-01-2021 Resignations - Appointments (NL)
04-02-2016 Resignations - Appointments (NL)
14-01-2010 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Lithi - Pharma?
The VAT number of Lithi - Pharma is BE 0449.135.041.
Wat is the PEPPOL ID of Lithi - Pharma?
The PEPPOL ID of Lithi - Pharma is 0208:0449135041. Log in or start a free trial to see the full overview.
When was Lithi - Pharma founded?
Lithi - Pharma was founded on 06-01-1993.
What is the address of Lithi - Pharma?
The current registered office of Lithi - Pharma is located at Oostendse Baan 86, 8470 Gistel.
When was the last time Lithi - Pharma filed their annual financial statements?
The most recent financial statements of Lithi - Pharma were filed on 01-01-2026.
How many employees does Lithi - Pharma have?
There are currently no employees working at Lithi - Pharma or no workforce information is available.
What is the annual turnover of Lithi - Pharma?
At the time of its most recent financial statements, Lithi - Pharma did not publish any turnover figures. Lithi - Pharma reported a gross margin of €149,752.28.